# Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study

> **NCT02949362** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 29 (actual)

## Conditions studied

- Short Bowel Syndrome

## Interventions

- **DRUG:** Teduglutide
- **OTHER:** SOC

## Key facts

- **NCT ID:** NCT02949362
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-09
- **Primary completion:** 2020-07-14
- **Final completion:** 2020-07-14
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2025-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02949362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02949362, "Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02949362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*